Eisai

4523.TSE

29.42 USD

0.54

+1.87%

Overview

Last close

29.42 usd

Market cap

8.29B usd

52 week high

36.12 usd

52 week low

24.09 usd

Target price

31.87 usd

Valuation

P/E

26.7844

Forward P/E

32.6797

Price/Sales

1.6348

Price/Book Value

1.4591

Enterprise Value

7.59B usd

EV/Revenue

1.5026

EV/EBITDA

10.981

Key financials

Revenue TTM

5.07B usd

Gross Profit TTM

3.94B usd

EBITDA TTM

558.68M usd

Earnings per Share

1.1 usd

Dividend

1 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in India. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.